tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX), Veracyte (VCYT) and AmerisourceBergen (ABC)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on RegenXBio (RGNXResearch Report), Veracyte (VCYTResearch Report) and AmerisourceBergen (ABCResearch Report).

RegenXBio (RGNX)

In a report released yesterday, Mani Foroohar from SVB Securities reiterated a Hold rating on RegenXBio, with a price target of $25.00. The company’s shares closed last Thursday at $34.74.

According to TipRanks.com, Foroohar has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -19.8% and a 35.9% success rate. Foroohar covers the Healthcare sector, focusing on stocks such as Arrowhead Pharmaceuticals, Recursion Pharmaceuticals, and 4D Molecular Therapeutics.

RegenXBio has an analyst consensus of Moderate Buy, with a price target consensus of $43.17, which is a 30.8% upside from current levels. In a report released yesterday, RBC Capital also maintained a Hold rating on the stock with a $47.00 price target.

See the top stocks recommended by analysts >>

Veracyte (VCYT)

SVB Securities analyst Puneet Souda maintained a Buy rating on Veracyte on August 2 and set a price target of $35.00. The company’s shares closed last Thursday at $27.66.

According to TipRanks.com, Souda has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -8.6% and a 40.5% success rate. Souda covers the Healthcare sector, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and Twist Bioscience.

Currently, the analyst consensus on Veracyte is a Strong Buy with an average price target of $32.33, which is a 26.3% upside from current levels. In a report released yesterday, Raymond James also maintained a Buy rating on the stock with a $31.00 price target.

AmerisourceBergen (ABC)

Mizuho Securities analyst Ann Hynes maintained a Hold rating on AmerisourceBergen on August 3 and set a price target of $162.00. The company’s shares closed last Thursday at $139.27.

According to TipRanks.com, Hynes is a 5-star analyst with an average return of 9.6% and a 61.7% success rate. Hynes covers the Healthcare sector, focusing on stocks such as Quest Diagnostics, Molina Healthcare, and Acadia Healthcare.

Currently, the analyst consensus on AmerisourceBergen is a Moderate Buy with an average price target of $171.67.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on RGNX:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More